Skip to the page

Data / Form D filings / Prenuvo, Inc.

Prenuvo, Inc.: Form D filing

Prenuvo, Inc., a health care company in Los Angeles, CA, filed a Form D with the SEC in 2025. The latest, on February 14, 2025, reports $85 million sold of a $90 million offering to 13 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
12100 WILSHIRE BOULEVARD STE 150, Los Angeles, CA, 90025
Phone
(778) 717-3694
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2028955

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Feb 14, 2025New notice$90,000,000$84,959,280$5,040,72013Jun 20, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Andrew LacyExecutive Officer, Director
Sundeep PeechuDirector
O'Malley BrianDirector

Other health care companies in California that filed recently

Every Form D from the week of Feb 10, 2025 · All recent filings in California · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Prenuvo, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.